Immunological Characteristics of Colitis Associated with Anti-CTLA-4 Antibody Therapy.
Bamias, Giorgos; Delladetsima, Ioanna; Perdiki, Marina; Siakavellas, Spyros I; Goukos, Dimitrios; Papatheodoridis, George V; Daikos, George L; Gogas, Helen.
; 35(7): 443-455, 2017 Aug 09.
Artigo em Inglês | MEDLINE | ID: mdl-28548891
Altered differentiation is central to HIV-specific CD4<sup>+</sup> T cell dysfunction in progressive disease.
CTLA-4 antibody ipilimumab negatively affects CD4<sup>+</sup> T-cell responses in vitro.
Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses.
[Anti-mouse CD(52) antibody ameliorates colitis through suppressing Th1/17 mediated inflammation and promoting regulatory T cell response in interleukin-10 deficient mice].
Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.
Can benign lymphoid tissue changes in <sup>18</sup>F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?
Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors.
Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
RORÎ³t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity.